230 related articles for article (PubMed ID: 35055657)
21. Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype.
de Heredia ML; Clèries R; Nunes V
Genet Med; 2013 Jul; 15(7):497-506. PubMed ID: 23429432
[TBL] [Abstract][Full Text] [Related]
22. Ophthalmic, systemic, and genetic characteristics of patients with Wolfram syndrome.
Ustaoglu M; Onder F; Karapapak M; Taslidere H; Guven D
Eur J Ophthalmol; 2020 Sep; 30(5):1099-1105. PubMed ID: 30957632
[TBL] [Abstract][Full Text] [Related]
23. [From gene to disease; mutations in the WFS1-gene as the cause of juvenile type I diabetes mellitus with optic atrophy (Wolfram syndrome)].
Pennings RJ; Dikkeschei LD; Cremers CW; van den Ouweland JM
Ned Tijdschr Geneeskd; 2002 May; 146(21):985-7. PubMed ID: 12058630
[TBL] [Abstract][Full Text] [Related]
24. Teaching NeuroImages: a neuroendocrine rarity: Wolfram syndrome.
Vale TC; Perpétuo FO
Neurology; 2013 Nov; 81(20):e153. PubMed ID: 24218323
[TBL] [Abstract][Full Text] [Related]
25. Homozygosity mapping and direct sequencing identify a novel pathogenic variant in the CISD2 gene in an Iranian Wolfram syndrome family.
Pourreza MR; Sobhani M; Rahimi A; Aramideh M; Kajbafzadeh AM; Noori-Daloii MR; Tabatabaiefar MA
Acta Diabetol; 2020 Jan; 57(1):81-87. PubMed ID: 31309279
[TBL] [Abstract][Full Text] [Related]
26. Wolfram syndrome with vitelliform retinal deposits.
Sabet SJ; Carey AR
Ophthalmic Genet; 2022 Feb; 43(1):116-119. PubMed ID: 34425740
[TBL] [Abstract][Full Text] [Related]
27. [Diabetes mellitus and optic atrophy: study of the Wolfram syndrome].
Rivas-Gómez B; Reza-Albarrán AA
Gac Med Mex; 2017; 153(4):466-472. PubMed ID: 28991271
[TBL] [Abstract][Full Text] [Related]
28. Three cases of Wolfram syndrome with different clinical aspects.
Çamtosun E; Şıklar Z; Kocaay P; Ceylaner S; Flanagan SE; Ellard S; Berberoğlu M
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):433-8. PubMed ID: 25210753
[TBL] [Abstract][Full Text] [Related]
29. Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome.
Sobhani M; Amin Tabatabaiefar M; Ghafouri-Fard S; Rajab A; Mozafarpour S; Nasrniya S; Kajbafzadeh AM; Noori-Daloii MR
Endocrine; 2019 Nov; 66(2):185-191. PubMed ID: 31313226
[TBL] [Abstract][Full Text] [Related]
30. Cataract as a phenotypic marker for a mutation in WFS1, the Wolfram syndrome gene.
Titah SM; Meunier I; Blanchet C; Lopez S; Rondouin G; Lenaers G; Amati-Bonneau P; Reynier P; Paquis-Flucklinger V; Hamel CP
Eur J Ophthalmol; 2012; 22(2):254-8. PubMed ID: 21623591
[TBL] [Abstract][Full Text] [Related]
31. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives.
Pallotta MT; Tascini G; Crispoldi R; Orabona C; Mondanelli G; Grohmann U; Esposito S
J Transl Med; 2019 Jul; 17(1):238. PubMed ID: 31337416
[TBL] [Abstract][Full Text] [Related]
32. Wolfram syndrome in the Japanese population; molecular analysis of WFS1 gene and characterization of clinical features.
Matsunaga K; Tanabe K; Inoue H; Okuya S; Ohta Y; Akiyama M; Taguchi A; Kora Y; Okayama N; Yamada Y; Wada Y; Amemiya S; Sugihara S; Nakao Y; Oka Y; Tanizawa Y
PLoS One; 2014; 9(9):e106906. PubMed ID: 25211237
[TBL] [Abstract][Full Text] [Related]
33. Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease.
Domenech E; Gomez-Zaera M; Nunes V
Pediatr Endocrinol Rev; 2006 Mar; 3(3):249-57. PubMed ID: 16639390
[TBL] [Abstract][Full Text] [Related]
34. Clinical Spectrum Associated with Wolfram Syndrome Type 1 and Type 2: A Review on Genotype-Phenotype Correlations.
Delvecchio M; Iacoviello M; Pantaleo A; Resta N
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33946243
[TBL] [Abstract][Full Text] [Related]
35. A novel compound heterozygous mutation in an adolescent with insulin-dependent diabetes: The challenge of characterizing Wolfram syndrome.
Maltoni G; Minardi R; Cristalli CP; Nardi L; D'Alberton F; Mantovani V; Zucchini S
Diabetes Res Clin Pract; 2016 Nov; 121():59-61. PubMed ID: 27657458
[TBL] [Abstract][Full Text] [Related]
36. Correction: Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease.
Rigoli L; Bramanti P; Di Bella C; De Luca F
Pediatr Res; 2018 Nov; 84(5):787. PubMed ID: 30171196
[TBL] [Abstract][Full Text] [Related]
37. A donor splice site mutation in CISD2 generates multiple truncated, non-functional isoforms in Wolfram syndrome type 2 patients.
Cattaneo M; La Sala L; Rondinelli M; Errichiello E; Zuffardi O; Puca AA; Genovese S; Ceriello A
BMC Med Genet; 2017 Dec; 18(1):147. PubMed ID: 29237418
[TBL] [Abstract][Full Text] [Related]
38. Wolfram syndrome type 1: a case series.
Du D; Tuhuti A; Ma Y; Abuduniyimu M; Li S; Ma G; Zynat J; Guo Y
Orphanet J Rare Dis; 2023 Nov; 18(1):359. PubMed ID: 37974252
[TBL] [Abstract][Full Text] [Related]
39. Next generation sequencing identifies a pathogenic mutation of WFS1 gene in a Moroccan family with Wolfram syndrome: a case report.
Sahli M; Zrhidri A; Boualaoui I; Cherkaoui Jaouad I; El Kadiri Y; Nouini Y; Sefiani A
J Med Case Rep; 2023 Sep; 17(1):409. PubMed ID: 37752530
[TBL] [Abstract][Full Text] [Related]
40. Association of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. The Wolfram or DIDMOAD syndrome.
Najjar SS; Saikaly MG; Zaytoun GM; Abdelnoor A
Arch Dis Child; 1985 Sep; 60(9):823-8. PubMed ID: 4051539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
